Blar i St. Olavs hospital på tidsskrift "Blood Advances"
Viser treff 1-2 av 2
-
Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis
(Peer reviewed; Journal article, 2020)Survival of patients with high-risk diffuse large B-cell lymphoma (DLBCL) is suboptimal, and the risk of central nervous system (CNS) progression is relatively high. We conducted a phase 2 trial in 139 patients aged 18 to ... -
Survival after cancer-related venous thrombosis: the Scandinavian Thrombosis and Cancer Study
(Peer reviewed; Journal article, 2023)Patients with cancer have an increased risk of developing venous thromboembolism (VTE), and this combination is reported to result in poorer survival compared with cancer alone. This study aimed to investigate the impact ...